Environmental and behavioral strategies include: Maintaining cooler ambient temperatures and using fans or air conditioning Wearing layered, breathable clothing made from natural fibers like cotton Avoiding known triggers such as spicy foods, caffeine, alcohol, and hot beverages Staying well-hydrated throughout the day Maintaining a healthy sleep environment with cool temperatures and moisture-wicking bedding Evidence-based non-pharmacologic approaches include cognitive behavioral therapy (CBT) and clinical hypnosis, which have demonstrated effectiveness for vasomotor symptoms
Encouraging results: Novo Nordisks Wegovy, for example, has shown a 20% reduction in heart attack, stroke, or death from heart disease in recent trials
Glucagon-like peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed
You should also be mindful of joint pain, a common side effect of letrozole, and ensure you stay hydrated to protect your kidneys
It may also help to boost compliance when injectables are not preferred and could be priced lower to reach a broader swathe of patients, especially outside the United States. Morgan Stanley: A broader and more lasting behavioral shift According to recent research from Morgan Stanley, its biopharma analysts expect the US anti-obesity medication (AOM) patient pool to increase fivefold to 24 million people (7% of the US population) over the next decade
